Two Sigma Advisers’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-644,726
| Closed | -$64M | – | 2562 |
|
|
2019
Q3 | $64M | Sell |
644,726
-1,018,400
| -61% | -$96.8M | 0.16% | 155 |
|
|
2019
Q2 | $154M | Sell |
1,663,126
-996,701
| -37% | -$94.6M | 0.38% | 53 |
|
|
2019
Q1 | $251M | Sell |
2,659,827
-565,300
| -18% | -$49.4M | 0.63% | 23 |
|
|
2018
Q4 | $207M | Buy |
3,225,127
+579,600
| +22% | +$42.8M | 0.56% | 27 |
|
|
2018
Q3 | $237M | Sell |
2,645,527
-459,700
| -15% | -$40.6M | 0.58% | 29 |
|
|
2018
Q2 | $247M | Buy |
3,105,227
+473,900
| +18% | +$39.3M | 0.66% | 21 |
|
|
2018
Q1 | $235M | Sell |
2,631,327
-502,800
| -16% | -$48.3M | 0.64% | 19 |
|
|
2017
Q4 | $327M | Buy |
3,134,127
+2,454,703
| +361% | +$277M | 0.88% | 6 |
|
|
2017
Q3 | $99.1M | Buy |
679,424
+632,537
| +1,349% | +$86.2M | 0.28% | 95 |
|
|
2017
Q2 | $6.09M | Sell |
46,887
-317,593
| -87% | -$38.9M | 0.02% | 675 |
|
|
2017
Q1 | $45.4M | Buy |
364,480
+144,681
| +66% | +$17.3M | 0.15% | 175 |
|
|
2016
Q4 | $25.4M | Sell |
219,799
-1,559,009
| -88% | -$174M | 0.1% | 250 |
|
|
2016
Q3 | $186M | Buy |
1,778,808
+1,693,322
| +1,981% | +$183M | 0.79% | 16 |
|
|
2016
Q2 | $8.43M | Buy |
85,486
+79,572
| +1,345% | +$8.23M | 0.04% | 409 |
|
|
2016
Q1 | $592K | Sell |
5,914
-3,129
| -35% | -$322K | ﹤0.01% | 1390 |
|
|
2015
Q4 | $1.08M | Sell |
9,043
-174,793
| -95% | -$20.2M | 0.01% | 991 |
|
|
2015
Q3 | $19.9M | Buy |
183,836
+174,296
| +1,827% | +$21.6M | 0.13% | 209 |
|
|
2015
Q2 | $1.1M | Buy |
+9,540
| New | +$1.09M | 0.01% | 1080 |
|
|
2015
Q1 | – | Sell |
-29,644
| Closed | -$3.32M | – | 2682 |
|
|
2014
Q4 | $3.32M | Buy |
+29,644
| New | +$3.13M | 0.03% | 624 |
|
|
2014
Q2 | – | Sell |
-10,986
| Closed | -$835K | – | 2893 |
|
|
2014
Q1 | $766K | Buy |
10,986
+7,800
| +245% | +$618K | 0.01% | 1310 |
|
|
2013
Q4 | $269K | Sell |
3,186
-35,200
| -92% | -$2.79M | ﹤0.01% | 1965 |
|
|
2013
Q3 | $2.95M | Sell |
38,386
-55,800
| -59% | -$3.91M | 0.04% | 472 |
|
|
2013
Q2 | $5.51M | Buy |
+94,186
| New | +$5.67M | 0.08% | 228 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Two Sigma Advisers's CELG Position: Q4 2019 in Review
Two Sigma Advisers sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 644,726 shares — an estimated $64M sold.
Two Sigma Advisers first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $327M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Two Sigma Advisers reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Two Sigma Advisers sold 644,726 Celgene Corp shares in Q4 2019, an estimated $64M.
- Two Sigma Advisers first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
- Two Sigma Advisers's Celgene Corp position peaked at $327M in Q4 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Two Sigma Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.